Page last updated: 2024-10-28

guanfacine and Hypertrophy, Left Ventricular

guanfacine has been researched along with Hypertrophy, Left Ventricular in 1 studies

Guanfacine: A centrally acting antihypertensive agent with specificity towards ADRENERGIC ALPHA-2 RECEPTORS.

Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.

Research Excerpts

ExcerptRelevanceReference
"The left ventricular end systolic stress-end systolic dimension (ESS-ESD) relation was used to assess the effect of regression in left ventricular hypertrophy on myocardial contractility in 14 hypertensive patients (mean age 47 years) treated with guanfacine (a sympatholytic central alpha-adrenergic agonist) for 10 weeks."3.67Contractile performance following regression of left ventricular hypertrophy in hypertensive patients. ( el-Said, G; Emile, H; Ibrahim, MM; Madkour, MA, 1985)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ibrahim, MM1
Emile, H1
Madkour, MA1
el-Said, G1

Other Studies

1 other study available for guanfacine and Hypertrophy, Left Ventricular

ArticleYear
Contractile performance following regression of left ventricular hypertrophy in hypertensive patients.
    Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1985, Volume: 3, Issue:3

    Topics: Adult; Guanfacine; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Myocardia

1985